| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
KRYS
Krystal Biotech
|
Aug 14, 2026 | BUY |
Strong Buy
-20.0% avg upside
20 analysts
|
$400.00
20.41% Upside
|
+0.0% | · |
|
FDMT
4D Molecular Therapeutics
|
Aug 14, 2026 | BUY |
Strong Buy
+194.9% avg upside
15 analysts
|
$35.00
187.04% Upside
|
+0.0% | · |
|
MGTX
Meiragtx Holdings
|
Aug 13, 2026 | BUY |
Strong Buy
+93.5% avg upside
13 analysts
|
$27.00
99.63% Upside
|
+6.7% | · |
|
MIRM
Mirum Pharmaceuticals
|
Aug 06, 2026 | BUY |
Strong Buy
+13.0% avg upside
22 analysts
|
$135.00
34.06% Upside
|
+6.9% | · |
|
VRDN
Viridian Therapeutics
|
Aug 06, 2026 | BUY |
Strong Buy
+59.5% avg upside
32 analysts
|
$36.00
63.01% Upside
|
-1.9% | · |
|
EYPT
EyePoint Pharmaceuticals
|
Aug 06, 2026 | BUY |
Strong Buy
+135.3% avg upside
20 analysts
|
$37.00
150.91% Upside
|
+15.0% | · |
|
IRD
Opus Genetics
|
Aug 06, 2026 | BUY |
Strong Buy
+187.7% avg upside
25 analysts
|
$9.00
149.24% Upside
|
-3.0% | · |
|
UTHR
United Therapeutics
|
Aug 05, 2026 | BUY |
Buy
-13.9% avg upside
26 analysts
|
$677.00
35.44% Upside
|
-3.7% | · |
|
RYTM
Rhythm Pharmaceuticals
|
Aug 04, 2026 | BUY |
Strong Buy
+8.0% avg upside
20 analysts
|
$155.00
34.13% Upside
|
+9.2% | · |
|
OCUL
Ocular Therapeutix
|
Aug 03, 2026 | BUY |
Strong Buy
+146.2% avg upside
21 analysts
|
$30.00
198.77% Upside
|
+19.5% | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.